» Articles » PMID: 39770144

Important Aspects of the Design of Experiments and Data Treatment in the Analytical Quality by Design Framework for Chromatographic Method Development

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2025 Jan 8
PMID 39770144
Authors
Affiliations
Soon will be listed here.
Abstract

In the analytical quality by design (AQbD) framework, the design of experiments (DOE) plays a very important role, as it provides information about how experimental input variables influence critical method attributes. Based on the information obtained from the DOE, mathematical models are generated and used to build the method operable design region (MODR), which is a robust region of operability. Data treatment steps are usually carried out in software such as Fusion QbD, Minitab, or StaEase 360, among others. Although there are many studies in the literature that use the DOE, none of them address important aspects of data treatment for optimization and MODR generation and compare different software calculations. The purpose of this study is to contribute to a better understanding of data treatment aspects that are frequently misread or not fully understood, such as model selection, ANOVA results, and residual analysis. The discussion will be guided by the separation of curcuminoids, using ultra-high performance liquid chromatography and eight quality attributes as responses. This study highlights the importance of carefully selecting and evaluating models, as they significantly influence the generation of the MODR. Moreover, the findings emphasize that it is essential to incorporate uncertainties into the contour plots to accurately determine the MODR in compliance with the ICH Q14 guidelines and USP General Chapter <1220>.

References
1.
Kurmi M, Jayaraman K, Natarajan S, Kumar G, Bhutani H, Bajpai L . Rapid and efficient chiral method development for lamivudine and tenofovir disoproxil fumarate fixed dose combination using ultra-high performance supercritical fluid chromatography: A design of experiment approach. J Chromatogr A. 2020; 1625:461257. DOI: 10.1016/j.chroma.2020.461257. View

2.
Peraman R, Bhadraya K, Reddy Y . Analytical quality by design: a tool for regulatory flexibility and robust analytics. Int J Anal Chem. 2015; 2015:868727. PMC: 4332986. DOI: 10.1155/2015/868727. View

3.
Yabre M, Ferey L, Some T, Sivadier G, Gaudin K . Development of a green HPLC method for the analysis of artesunate and amodiaquine impurities using Quality by Design. J Pharm Biomed Anal. 2020; 190:113507. DOI: 10.1016/j.jpba.2020.113507. View

4.
Abreu J, Mahr A, do Lago C . Stability-indicating method development for quantification of bromopride, its impurities, and degradation products by ultra-high performance liquid chromatography applying Analytical Quality by Design principles. J Pharm Biomed Anal. 2021; 205:114306. DOI: 10.1016/j.jpba.2021.114306. View

5.
Candioti L, De Zan M, Camara M, Goicoechea H . Experimental design and multiple response optimization. Using the desirability function in analytical methods development. Talanta. 2014; 124:123-38. DOI: 10.1016/j.talanta.2014.01.034. View